Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma.

CONCLUSIONS: Reduced-dose R-CHOP chemotherapy is a promising treatment for elderly patients with DLBCL in terms of efficacy and toxicity. PMID: 30101679 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30101679?dopt=Abstract

Source: Hematology - August 15, 2018 Category: Hematology Tags: Hematology Source Type: research